Insider · CIK 0001816988
Marc Forth
Files at AEON (AEON Biopharma, Inc.). First filing -, latest -.
In brief
Marc Forth files SEC Form 4 as director and CEO at AEON (AEON Biopharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marc Forth has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | AEON AEON Biopharma, Inc. | AGrant or award Class A Common Stock | +222,684 | $0.00 | $0 | 973,231 | Jun 22, 2026 |
| May 21, 2025 | AEON AEON Biopharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +370,370 | $0.00 | $0 | 370,370 | May 23, 2025 |
| Mar 19, 2024 | AEON AEON Biopharma, Inc. | AGrant or award Stock Optionderivative | +212,466 | $0.00 | $0 | 212,466 | Mar 21, 2024 |
Questions about Marc Forth
Answered from the filings on this page, as of the latest one.
Is Marc Forth buying or selling?
Marc Forth has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marc Forth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marc Forth has 0.
Where does Marc Forth file Form 4?
Marc Forth has filed Form 4 at AEON (AEON Biopharma, Inc.) as CHIEF EXECTUIVE OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.